Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar C Boedeker

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Opinion in Gastroenterology|February 11, 2005
Gastrointestinal infections: an overviewEdgar C Boedeker
Current Opinion in Gastroenterology|February 9, 2005
Gastrointestinal infectionsEdgar C Boedeker
Current Opinion in Gastroenterology|November 30, 2006
Gut microbes, the innate immune system and inflammatory bowel disease: location, location, locationEdgar C Boedeker
Current Opinion in Gastroenterology|February 3, 2005
Vaccines for enterotoxigenic Escherichia coli: current statusEdgar C Boedeker
Current Opinion in Gastroenterology|February 3, 2005
Enteric infectionsEdgar C Boedeker
Current Opinion in Gastroenterology|November 29, 2007
Gastrointestinal infections, an overview: from pathogens to metagenomesEdgar C Boedeker
Current Opinion in Gastroenterology|November 29, 2007
Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infectionsAntonio Serna, Edgar C Boedeker
Veterinary Immunology and Immunopathology|November 6, 2012
Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulationWyatt Byrd, Edgar C Boedeker
Current Opinion in Gastroenterology|October 13, 2006
Helicobacter pylori infection: treatmentLila Belhoussine-Idrissi, Edgar C Boedeker
Veterinary Microbiology|May 22, 2017
Development of live attenuated bacterial vaccines targeting Escherichia coli heat-labile and heat-stable enterotoxinsChengru Zhu, Prashanth Setty, Edgar C Boedeker
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Opinion in Gastroenterology|February 11, 2005
Gastrointestinal infections: an overviewEdgar C Boedeker
Current Opinion in Gastroenterology|February 9, 2005
Gastrointestinal infectionsEdgar C Boedeker
Current Opinion in Gastroenterology|November 30, 2006
Gut microbes, the innate immune system and inflammatory bowel disease: location, location, locationEdgar C Boedeker
Current Opinion in Gastroenterology|February 3, 2005
Vaccines for enterotoxigenic Escherichia coli: current statusEdgar C Boedeker
Current Opinion in Gastroenterology|February 3, 2005
Enteric infectionsEdgar C Boedeker
Current Opinion in Gastroenterology|November 29, 2007
Gastrointestinal infections, an overview: from pathogens to metagenomesEdgar C Boedeker
Current Opinion in Gastroenterology|November 29, 2007
Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infectionsAntonio Serna, Edgar C Boedeker
Veterinary Immunology and Immunopathology|November 6, 2012
Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulationWyatt Byrd, Edgar C Boedeker
Current Opinion in Gastroenterology|October 13, 2006
Helicobacter pylori infection: treatmentLila Belhoussine-Idrissi, Edgar C Boedeker
Veterinary Microbiology|May 22, 2017
Development of live attenuated bacterial vaccines targeting Escherichia coli heat-labile and heat-stable enterotoxinsChengru Zhu, Prashanth Setty, Edgar C Boedeker
Pageof 4